Halia Therapeutics, Inc.
Clinical trials sponsored by Halia Therapeutics, Inc., explained in plain language.
-
New combo therapy for diabetes and obesity tested – but study pulled
Disease control TerminatedThis study aimed to see if adding a new drug called ofirnoflast to semaglutide helps control blood sugar and promote weight loss better than semaglutide alone in overweight or obese adults with type 2 diabetes. Participants would have taken the drugs for 12 weeks. However, the st…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 07:38 UTC
-
New pill aims to boost blood counts in MDS patients with stubborn anemia
Disease control OngoingThis study tests an experimental drug called HT-6184 in adults with a low-risk type of bone marrow disorder (MDS) who have anemia that hasn't improved with standard treatments. The goal is to see if the drug can improve blood cell counts and reduce the need for blood transfusions…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC